Scinai Immunotherapeutics (SCNI) Other Non-Current Liabilities (2017 - 2025)
Scinai Immunotherapeutics (SCNI) reported Other Non-Current Liabilities of $3000.0 for Q2 2025, little changed on a YoY basis from $3000.0 in Q2 2024, and little changed sequentially from $3000.0 in Q4 2024.
Scinai Immunotherapeutics (SCNI) Other Non-Current Liabilities (2017 - 2025) Analysis & Trends
Scinai Immunotherapeutics (SCNI) has 8 years of Other Non-Current Liabilities data on file, last reported at $3000.0 in Q2 2025.
- For the quarter ending Q2 2025, Other Non-Current Liabilities changed 0.0% year-over-year to $3000.0; the trailing twelve-month figure through Jun 2025 stood at $3000.0 (changed 0.0% YoY), and the FY2024 full-year result was $3000.0, down 96.88% from the prior year.
- Other Non-Current Liabilities was little changed at $3000.0 in Q2 2025, from $3000.0 in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $5.3 million in Q4 2022 to a low of $3000.0 in Q2 2024.
- A 4-year average of $1.0 million and a median of $96000.0 in 2023 frame the typical range for Other Non-Current Liabilities.
- Across the five-year window, Other Non-Current Liabilities sank 99.67% in 2024 and changed 0.0% in 2025, its largest moves.
- Tracing SCNI's Other Non-Current Liabilities over 4 years: stood at $5.3 million in 2022, then slumped by 98.2% to $96000.0 in 2023, then tumbled by 96.88% to $3000.0 in 2024, then changed by 0.0% to $3000.0 in 2025.
- Business Quant data shows SCNI's Other Non-Current Liabilities at $3000.0 in Q2 2025, $3000.0 in Q4 2024, and $3000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Scinai Immunotherapeutics | 352,860.00 | -3.11 Bn | -1.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3,000.00 |
| Dec 31, 2024 | 3,000.00 |
| Sep 30, 2024 | 3,000.00 |
| Jun 30, 2024 | 3,000.00 |
| Dec 31, 2023 | 96,000.00 |
| Sep 30, 2023 | 311,000.00 |
| Jun 30, 2023 | 902,000.00 |
| Mar 31, 2023 | 2.66 Mn |
| Dec 31, 2022 | 5.33 Mn |
| Dec 31, 2020 | -14.81 Mn |
| Sep 30, 2020 | -14.81 Mn |
| Jun 30, 2020 | 12.69 Bn |
| Mar 31, 2020 | 12.99 Bn |
| Dec 31, 2019 | 4.29 Mn |
| Sep 30, 2019 | 4.15 Mn |
| Jun 30, 2019 | 4.10 Mn |
| Mar 31, 2019 | 4.01 Mn |
| Dec 31, 2018 | 3.91 Mn |
| Sep 30, 2018 | 3.57 Mn |
| Jun 30, 2018 | 3.50 Mn |